Challenges and strategies of clinical application of CAR-T therapy in the treatment of tumors—a narrative review

Chimeric antigen receptor T-cell (CAR-T) therapy has achieved good therapeutic efficacy in the treatment of hematological malignancies. In August 2017, Novartis Kymriah (CAR-T cells targeting CD19) was approved by the FDA, indicating the real entry of CAR-T cell therapy into clinical applications an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weijing, Wu, Lili, Huang, Chen, Liu, Ruixia, Li, Zheng, Liu, Lihong, Shan, Baoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575947/
https://www.ncbi.nlm.nih.gov/pubmed/33145312
http://dx.doi.org/10.21037/atm-20-4502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575947/
https://www.ncbi.nlm.nih.gov/pubmed/33145312
http://dx.doi.org/10.21037/atm-20-4502

Ejemplares similares